openPR Logo
Press release

Restless Legs Syndrome - Drug Pipeline Landscape, 2022

09-01-2022 12:13 PM CET | Health & Medicine

Press release from: Global Insight Services

Restless Legs Syndrome - Drug Pipeline Landscape

Restless Legs Syndrome - Drug Pipeline Landscape

Restless Legs Syndrome (RLS) is a neurological disorder characterized by an irresistible urge to move one's legs. The exact cause of RLS is unknown, but it is thought to be associated with a dysfunction in the brain's dopamine system. This system is responsible for regulating movement and is also involved in the feeling of pleasure and reward. RLS is thought to be caused by a combination of genetic and environmental factors. Other conditions that contribute to RLS include low levels of iron (iron deficiency), uremia, hypothyroidism, depression, fibromyalgia and Parkinson's disease.

Symptoms of RLS include leg (or arm) discomfort, urge to move legs, sleep disruption, bedtime behavior problems and daytime sleepiness.

Healthcare provider may conduct a physical and a neurological exam. Other tests like blood tests may be recommended.

Read more about Restless Legs Syndrome - Drug Pipeline here: https://www.globalinsightservices.com/reports/restless-legs-syndrome-drug-pipeline-landscape-2022/

Restless legs syndrome can be treated with non-drug treatments like regular exercise, good sleeping habits and iron supplementation prescription medications like dopamine agonists and anti-seizure medications.

RLS is a relatively common disorder, affecting up to 10% of the population. It is more common in women and people of European descent. RLS is often associated with other conditions, such as iron deficiency, pregnancy, and certain neurological disorders.

There is no cure for RLS, but treatments are available to help relieve the symptoms. These include dopaminergic medications, iron supplements, and lifestyle changes.

Report Highlights:

Global Insight Service's, Restless Legs Syndrome - Drug Pipeline Landscape, 2022 report provides an overview of the Restless Legs Syndrome pipeline drugs. This report covers detailed insights on Restless Legs Syndrome drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Restless Legs Syndrome pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS31017/

Methodology:

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope:

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS31017/

Key Players:
- Axim Biotechnologies Inc
- Bioprojet SCR
- Luye Pharma Group
- Omeros Corp

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Restless Legs Syndrome - Drug Pipeline Landscape, 2022 here

News-ID: 2721668 • Views:

More Releases from Global Insight Services

Gene Editing Service Market Expected to Expand From $2.8 Billion in 2024 to $9.7 Billion by 2034 | Overall Study Report 2035
Gene Editing Service Market Expected to Expand From $2.8 Billion in 2024 to $9.7 …
The Gene Editing Service Market is witnessing rapid growth, driven by advancements in biotechnology and increased demand for precise genetic modification solutions. This market focuses on providing services and technologies for altering genetic material with high accuracy, enabling transformative applications in therapeutics, agriculture, and industrial biotechnology. Tools such as CRISPR-Cas9, TALENs, and Zinc Finger Nucleases are central to this market, offering tailored solutions for gene knockouts, knock-ins, and other modifications.
Epigenomics Market Projected to Reach $11.6 Billion by 2034, Growing at 13.1% CAGR | Overall Study Report
Epigenomics Market Projected to Reach $11.6 Billion by 2034, Growing at 13.1% CA …
The Epigenomics Market is evolving as one of the most promising areas in modern healthcare and biotechnology. Unlike traditional genetics, epigenomics focuses on changes in gene expression without altering the DNA sequence itself. This science studies mechanisms such as DNA methylation, histone modification, and non-coding RNA, which influence how genes behave. With applications spanning oncology, neurology, cardiology, and drug development, the epigenomics market is becoming central to personalized medicine. It
E-invoicing Market Is Anticipated To Expand From $18.6 Billion In 2024 To $78.9 Billion By 2034
E-invoicing Market Is Anticipated To Expand From $18.6 Billion In 2024 To $78.9 …
Market Overview The E-invoicing Market is undergoing a major transformation as businesses worldwide shift towards digital and automated financial processes. The market is anticipated to expand from $18.6 billion in 2024 to $78.9 billion by 2034, growing at an impressive CAGR of approximately 15.5%. This growth reflects the global trend of digitization and the increasing need for transparency, efficiency, and compliance in financial operations. E-invoicing-short for electronic invoicing-replaces traditional paper-based billing
Eco Friendly Food Packaging Market Is Anticipated To Expand From $380.4 Billion In 2024 To $741.5 Billion By 2034
Eco Friendly Food Packaging Market Is Anticipated To Expand From $380.4 Billion …
Market Overview The Eco friendly Food Packaging Market is rapidly transforming the global food industry by promoting sustainability and reducing environmental impact. As consumers and governments alike emphasize green practices, companies are shifting from traditional plastic packaging to biodegradable, recyclable, and compostable alternatives. These sustainable materials include paper, cardboard, and plant-based plastics that help minimize waste generation and carbon footprints. The market supports the transition toward a circular economy, encouraging brands

All 5 Releases


More Releases for Restless

Restless Legs Syndrome Treatment Market Opportunities and Forecast Upto 2024
Global Restless Legs Syndrome Treatment Market: Overview Restless legs syndrome, also called Willis-Ekbom disease, is a neurological disorder. It triggers an urge in patients to move their legs. Because the syndrome usually occurs during sleep, it is also considered a type of sleep disorder. People suffering from restless legs syndrome often feel an overwhelming desire to rigorously move their legs, the intensity and frequency of which leads to unpleasant pain in
Restless Legs Syndrome - Pipeline Review And Market Research Report 2017
A latest research report titled as ”Restless Legs Syndrome - Pipeline Review And Market Research Report 2017” has been recently added to the vast portfolio of Market Research Hub (MRH) online research offerings. This report is a professional and in-depth analysis on the present state and future prospect for the global market. It provides valuable information to the industry insiders, potential entrants or investors. It includes an exhaustive enquiry with
Restless Legs Syndrome – Pipeline Share, Trends and Research Report (2017)
Albany, New York, March 15, 2017: Market Research Hub has recently announced the report on “Restless Legs Syndrome”. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restless Legs Syndrome Pipeline Review, H1 2017, provides an overview of the Restless Legs Syndrome (Central Nervous System) pipeline landscape. Request a Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1021063 Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a disorder of the part of the
Restless Legs Syndrome - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Pulmonary Restless Legs Syndrome - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restless Legs Syndrome - Pipeline Review, H1 2017, provides an overview of the Restless Legs Syndrome (Central Nervous System) pipeline landscape. Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a disorder
Global Restless Legs Syndrome Consumption 2016 Market Research Report
ReportBazzar has announced a new report titled "Global Restless Legs Syndrome Consumption 2016 Market Research Report" To their offerings Browse Report Summary with TOC: http://www.reportbazzar.com/product/global-restless-legs-syndrome-consumption-2016-market-research-report/ The Global Restless Legs Syndrome Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Restless Legs Syndrome market. First, the report provides a basic overview of the Restless Legs Syndrome industry including definitions, classifications, applications and industry chain structure. And
Restless Leg Syndrome and Insomnia Linked to Magnesium Deficiency
Restless leg syndrome (RLS) is a form of insomnia characterized by an overwhelming urge to move the legs when they are at rest, especially during sleep. RLS affects about 10% of the people in the U.S. It runs in families and may have a genetic component. Recent research has found that people with restless leg syndrome are deficient in the mineral magnesium. According to the National Sleep Foundation, almost